Ginsenoside Rd was found to reduce intracellular ROS production in cardiomyocytes through PI3K/Akt/Glycogen synthase kinase-3 beta (GSK3β) signaling inhibits mitochondria-dependent apoptosis during MI/RI (Wang et al., 2013). Here, GSK3B is linked to myocardial infarction.